Information on Cancer
users and public
qui som?
presentation
objectives and politics
strategic lines
model of management
services, units and areas
area of nursing
comissió farmacoterapèutica
human resources
publications
oncolinks
epidemiology and prevention area
research
training
ICO L'Hospitalet
ICO Badalona
ICO Girona
 
web de la Fundació
 
pla director d'Oncologia
 
 
  MEDICINE'S ALPHABETICAL LIST + DATE ORDER
  Medicine
Report Complementary Report
Àcid Zoledrònic
Amifostina
Anastrazol
Aprepitant
Azacitidina
Bevacizumab
Bicalutamida
Bortezomib
Buprenorfina
Busulfan
Caspofungina
Cetuximab
Cetuximab CCRm K-ras Wild
Cetuximab SCCHN 1ªL
Cetuximab SCCHN
Citarabina Liposomal
Dasatinib
Darbepoetina Alfa
Dexrazoxano
Docetaxel
Doxorubicina Liposomal
Doxorubicina Liposomal-PEG
Eculizumab
Epoetina Zeta
Erlotinib
Fentanil Oral Transmucosa
Filgrastim
Fotemustina
Gemcitabina
Ibandronat
Ibritumomab tiuxetà
Imatinib GIST
Imatinib Tractament LMC
Lenalidomida
Lapatinib
Nilotinib
Oxaliplatí
Oxicodona
Palifermina
Palonosetrón
Pegfilgrastim
Pemetrexed
Posaconazol
Rituximab
Sorafenib
Sunitinib
Talidomida
Temozolomida
Temsirolimus
Trabectidina
Trastuzumab
Valaciclovir
Valganciclovir
Vinorelbina
Vinorelbina oral
Voriconazol